Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Eplerenone on Intraocular Pressure in Healthy Adults
NCT07795762Phase 1Not yet recruiting
- Sponsor
- University of Florida
- Start
- Oct 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of eplerenone in ocular hypertension (2 arms), sponsored by University of Florida. Primary endpoint: Intraocular Pressure at Day 28. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
eplerenone
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT07795762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07795762.